RXRX

#1795
Recursion Pharmaceuticals, Inc. Class A Common Stock
3.67
+2.51%
Secteur:
Base:
Devise de Profit:
Range quotidien
3.67
3.67
Range Annuel
2.98
7.89
Changement quotidien
+2.51%
Changement Mensuel
-20.91%
Evolution sur 6 mois
-25.10%
Changement Annuel
-45.22%
Clôture Précédente
3.58
Open
3.67
Bid
Ask
Low
3.67
High
3.67
Volume
139
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.64 B
  • Employee 800
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.84
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

Nouvelles